By analyzing genomic profiles of StAR and steroidogenic enzyme genes for several hormone sensitive cancers, our data extend previous observations and provide novel insight that aberrant high amplification/expression of the StAR gene is correlated with poor survival of patients with breast cancer. Here, STAR is linked to breast carcinoma.